technetium tc 99m mertiatide has been researched along with Carcinoma, Transitional Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arata, R; Kumon, H; Nasu, Y; Saika, T; Shirasaki, Y; Tsushima, T | 1 |
1 other study(ies) available for technetium tc 99m mertiatide and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
Predicting postoperative renal insufficiency in patients undergoing nephrectomy for renal malignancy: assessment by renal scintigraphy using 99mtechnetium-mercaptoacetyltriglycine.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Nephrectomy; Predictive Value of Tests; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Renal Insufficiency; Technetium Tc 99m Mertiatide | 2005 |